Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-06-02 16:50:22
Reporting Period:
Accepted Time:
2020-06-02 16:50:22
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1582313 Xenon Pharmaceuticals Inc. XENE Pharmaceutical Preparations (2834) 980661854
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1620084 N. Simon Pimstone 200 - 3650 Gilmore Way
Burnaby A1 V5G 4M1
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2020-05-29 5,000 $13.99 258,186 No 4 S Direct
Common Shares Disposition 2020-06-01 3,000 $14.43 255,186 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 16,460 Indirect Spouse
  1. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $13.99 to $14.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein